Volume 20 No 9 (2022)
Download PDF
The role of sST2 as biochemical markers for cardiac fibrosis in patients with Myocardial Infarction
Mahmoud Hassan Ali, Dr. Shaymaa Z.Nada, Dr. Lamya A.Darwish
Abstract
In Iraq, ischemic heart disease ranks first among the top ten killers with a mortality rate of 11.2 percent,
and it ranks fourth among the top ten causes of hospitalization with a 5.35 percent rate in 2020. A
myocardial infarction (MI) happens when blood flow to the heart's coronary artery is reduced or
interrupted, harming the heart muscle. When the heart needs more blood flow—during activity or
excitement—this situation tends to happen more frequently. is a widespread occurrence in Iraq and the
world's greatest cause of mortality.The Suppression of Tumorigenicity 2 protein (ST2) is a member of
the interleukin (IL) 1 receptor family with transmembrane (ST2L) and soluble (sST2) isoforms that are
expressed in several cells in different conditions and following various triggers (e.g. inflammation,
stress).
Keywords
Suppression of Tumorigenicity 2, sST2, myocardial infarction
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.